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Abstract
Diabetes mellitus type II affects around 8 percent of the total adult population in the world. It is the
fifth leading cause of death in high income countries and an epidemic in developing countries. We
analyze protein-protein interaction data of the pancreatic cells for normal and disease states. The
analysis exhibits overall structural similarities in the normal and disease networks. The important
differences are revealed through specific interaction patterns and eigenvector analyses. The top
contributing nodes from localized eigenvectors as well as those being part of specific interaction
patterns turn out to be significant for the occurrence of the disease. The analysis provides a direction
for further development of novel drugs and therapies in curing the disease by targeting specific
patterns instead of a single node.
Introduction
Diabetes mellitus type II (DM-II) is a metabolic disorder which is characterized by resistance to
insulin and abnormalities in the hepatic cells in terms of glucose production [1]. It has been known
to be a complex and multi factorial disease [2] as it affects various other organ systems in the body
like cardiovascular system, kidneys, lungs, eyes etc [3,4]. The WHO statistics reveals that DM-II has
affected nearly 325 million people till 2013 out of which 46% cases are undiagnosed and the disease
show rising trend world-wide [5–7]. Diabetes is known to cause 5.1 million death in 2013 and statistical
data reveals that every six seconds a person dies from diabetes further probing that it is the fifth
leading cause of death in high income countries and an epidemic in developing countries [8, 9]. It is
one of the most important non-communicable diseases of the 21st century accounted both in terms of
mortality and morbidity [10]. Indecent lifestyle, increased urbanization and unhealthy behaviors are
some of the major causes behind the disease [11]. Recent biological studies indicate that significant
increase in population having obesity has in turn become a major reason for higher DM-II cases [12].
Some genome wide studies reveal genetic basis of DM-II by finding some important proteins which are
heritable and cause DM-II further indicating that dysfunctioning of beta cells is another reason for
the occurrence of the disease apart from insulin resistance [13]. This disease is likely to increase the
burden of chronic diabetic complications worldwide in the near future [14–16]. It has been found that
treatment of people with diabetes account for up to 15% of international health care budgets [17,18].
According to a recent study, a person with this complex disease spends on an average more than
$85, 000 in the treatment and its complications over entire lifetime and trillion dollars are spent on
health and diseases worldwide [18]. An early detection may help in cure to the people with this
disease. But the research pertaining to development of novel treatments and cure methods is very
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exhaustive [8]. Even after enormous investment in pharmacological research and clinical trials in the
past decades, there has not been proportionate advancement in clinical results. All these demand for
a new perspective in disease research, which we provide here using combined framework of random
matrix theory and network theory. This framework predicts important structural patterns crucial
for disease is very time efficient and cost effective.
Previously, a network analysis of PPI netwok of DM-II reveals potential drug targets on the basis
of candidate genes involved in DM-II [19]. Few network studies done also reveal some important
pathways associated with insulin signaling using high-throughput micro-array datasets [20–22]. DM-
II investigated using systems biology approach highlights the occurrence of the disease. These studies
are based on a handful of disease-associated proteins, while our investigation for the first time per-
forms extensive analysis of the whole pancreatic cell proteins. We investigate DM-II at the proteomic
level using network biology along with the random matrix theory (RMT). This mathematical the-
ory has been formulated six decades ago in order to understand complex nucleons interactions [23].
Later on, the theory has shown its remarkable success in understanding various complex systems
ranging from quantum chaos to galaxy [24–28]. In the current work, we construct the protein-protein
interaction (PPI) network of DM-II by analyzing normal and disease states of pancreatic cells and
investigate their structural properties, which is further compared with the properties of random net-
works. The analysis reveals specific structural patterns, as well as nodes contributing significantly to
the most localized eigenvector being crucial for the occurrence of the disease.
Materials and Methods
Data assimilation and network construction
We study the PPI network of DM-II, where nodes are the proteins and edges denote the interactions
between these proteins. After diligent and enormous efforts, we collect the protein interaction data
from various literature and bioinformatic sources. To keep the authenticity of the data intact, we
only take the proteins into account which are reviewed and cited. We consider two widely used
bioinformatic databases namely Genbank from NCBI [29] and UNIPROT constituting data available
from other resources like European Bioinformatic Institute, the Swiss Institute of Bioinformatics, and
the Protein Information Resource [30]. To add more information, we take highly studied diabetes
mellitus II cell lines whose protein expression data is known. Here, we use the protein expression
data of EndoC− β H1 cells in the disease dataset [31]. Since there are a very few human cell lines
available, we take the mouse and rat cell lines namely MIN and INS-1, proteins of which have already
been proved to behave similarly in humans [32,33]. After collecting the proteins for both the datasets,
their interacting partners are downloaded from STRING database [34]. We take into account largest
sub-networks from the normal as well as from the disease data and investigate their structural and
spectral properties.
Structural measures
There are several structural measures used enormously in the last fifteen years in order to understand
and characterize the properties of a network [35]. Here we define only those which are useful for our
analysis. To start with, let us first define the interaction matrix or the adjacency matrix of the
network as follows:
Aij =
{
1 if i ∼ j
0 otherwise
(1)
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The most basic structural parameter of a network is the degree of a node (ki), which is defined as
the number of neighbors the node has (ki =
∑
j Aij). The degree distribution p(k), revealing the
fraction of vertices with degree k, is known as the fingerprint of the network [35]. Another important
parameter is the clustering coefficient (CC) of the node (i), which is defined as the ratio of the number
of connections a particular node has and the possible number of connections that particular node
can have. Clustering coefficient of a network can be written as
〈CC〉 = 1
n
n∑
i=1
CCi (2)
The average clustering coefficient of the network characterizes the overall tendency of nodes to form
cluster or groups. Further, the betweenness centrality of a node is defined as the fraction of shortest
paths between node pairs that pass through the said node of interest [36]. Another important
parameter is the diameter of the network which measures the longest of the shortest paths between
all the pair of nodes [35].
Spectral techniques
Eigenvalues of adjacency matrix (Eq. 1) denoted as λ1 > λ2 > λ3 > . . . > λN is referred as network
spectra. Further, we use the inverse participation ratio (IPR) to analyze localization properties of
the eigenvectors. The IPR of kth eigenvector Ek with its lth component being denoted by Ekl , can
be defined as
Ik =
∑N
l=1[E
k
l ]
4
(
∑N
l=1[E
k
l ]
2)2
(3)
which shows two limiting values : (i) a vector with identical components Ekl ≡ 1/
√
N has Ik = 1/N ,
whereas (ii) a vector, with one component Ek1 = 1 and the remainders being zero, has I
k = 1.
Thus, the IPR quantifies the reciprocal of the number of eigenvector components that contribute
significantly. An eigenvector whose components follow Porter-Thomas distribution yields Ik=3/N
[37], and those which are deviating from this value provide system dependent information [38]. We
further calculate the average value of IPR, in order to measure an overall localization of the network
calculated as
〈IPR〉 =
∑N
k=1 I
k
N
(4)
Results and Discussions
Structural properties
The normal dataset has 4613 nodes (proteins) and 26035 connections (interactions) among them,
while the disease dataset comprises of 1100 nodes and 5578 connections exhibiting that the disease
data consists of less number of proteins as well as connections than the normal one. One of the possible
reasons behind this could be less availability of data for the disease state as already discussed under the
data assimilation section. Another possible reason could be that in the disease state, many pathways
are silenced or levels of protein expressions are altered leading to less number of proteins [39]. The
normal and the disease datasets lead to many connected clusters or sub-networks, whose sizes are
summarized in the first column of Table. 1. The next column in Table. 1 conveys that even with less
number of nodes, the disease sub-networks possess almost same (〈k〉) as the normal ones. Further,
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Table 1: Detailed parameters for normal and disease sub-networks
Network N NC 〈k〉 D 〈CC〉 Nclus=1 〈IPR〉 λ0 λ−1
Normal-1 2083 11017 10 17 0.35 6.1% 0.010 3.1% 1.8%
Normal-2 1705 9888 11 12 0.33 6.2% 0.008 3.5% 1.8%
Disease-1 656 3628 11 10 0.36 6.0% 0.015 3.6% 1.06%
Disease-2 384 1882 10 9 0.46 7.8% 0.032 7.2% 4.9%
The columns represent the total number of proteins (nodes) in the network N collected using
various databases (described in the Method section), number of connections in the sub-networks
NC , the average degree 〈k〉, diameter (D), average clustering coefficient 〈CC〉, the number of nodes
having CC = 1 in the whole network (Nclus=1), average IPR 〈IPR〉, and number of degenerate
eigenvalues in the whole network λ0 and λ−1 for the sub-networks of both the normal and the
disease state.
the disease sub-networks show relatively lower diameter as compared to the normal one. Since small
diameter facilitates a fast communication [40], up-regulation and down-regulation of pathways may
be one of the reasons behind faster signaling leading to the disease state. Further, we calculate the
average clustering coefficient of all the sub-networks along with the total number of nodes having
CC equal to one (Nclus=1) as tabulated in Table. 1. The percentage of nodes having this property for
the normal and all the disease sub-networks, except D − 2, are approximately same. For D − 2, the
number of nodes having CC = 1 is slightly higher as compared to other sub-networks indicating the
presence of more clique structures in this sub-network. Importance of cliques and relevance of this
structure for the disease will become more clear in the section “preserved structure through clique
formation” section.
Figure 1: Degree distribution. Degree distribution for the normal (N − 1 and N − 2) and disease
(D − 1 and D − 2) datasets following the power law behavior of GOE statistics.
The degree distribution p(k) of both the normal and the disease sub-networks follow power law
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(Figure. 1) indicating that few nodes have very high degree. Earlier studies on structural analysis
of DM-II network also emphasize on proteins having large number of interactions being functionally
important [41]. Since the present investigation uses a much larger number of proteins and interactions
as compared to any other work done on DM-II, our datasets reveal new proteins that comes out
to be top in the degree distribution. The bigger dataset used in our investigation arises due to the
following two reasons, first, we have made exhaustive literature search for almost all the authenticated
databases to construct our dataset, and second, there is revelation of new proteins and interactions
since 2008 [41] contributing to additional interactions to the proteins in our dataset.
In the first disease sub-network, UBB and UBA-52 are the highest degree nodes, while for the
second sub-network, UBI-15, INS, ALB and BBS-12 come out to be significant. We find that, these
nodes are involved in insulin production and are known to be regulated in the disease state leading
to less production of insulin. The detailed functional description of high degree nodes is deferred
to the supplementary material. Further, since the power law degree distribution is known to confer
robustness to the underlying network against random external perturbations as well as to instill
complexity in the corresponding system [35], the similar behavior exhibited by the disease and normal
networks bring them into the same universality class of other complex biological systems [42]. What
follows that, overall structural properties such as diameter, clustering coefficient, average degree and
degree distribution of disease and normal sub-networks are similar indicating complex interactions
and fast dissemination of information in the pancreatic cell which is in the line of other complex
systems. The important differences between the disease and normal states are revealed when we
analyze nodes forming complete sub-graphs as well as those appearing in spectral analysis under the
RMT framework.
Preserved structures through clique formation
All the sub-networks have very high value of 〈CC〉 as depicted in Table. 1. This implicates the pres-
ence of high number of triangles or cliques of order three [40]. Cliques indicate preserved interactions
in the networks and are believed to be conserved during evolution [43]. Further, these structures
are also considered to be the building blocks of a network for making the underlying system more
robust [44] and stable [45]. Therefore, we hope to bring out important information by analyzing
these patterns in details. We focus on the nodes having CC = 1 and which are common in both
the networks. It turns out that, there are 34 nodes appearing common in the normal and disease
datasets. We perform extensive functional analysis of these nodes to study the differences in both
the states as these proteins enjoy special structural feature in the networks.
Biological significance of proteins involved in preserved structures
The functional properties of these nodes reveal that out of 34 there are six proteins, namely ADAMTS9,
G5A, PIK3C2A, VAPA, SPTBN2 and CTNNB2, which are responsible for regulating the levels of
insulin in the blood leading to insulin resistance which is a primary symptom of the occurrence of
type 2 diabetes in an individual [46]. Another set of proteins having CC = 1 namely NR2C2, AGER,
CACNA1D and CD59 are involved in the abnormal secretion and absorption of glucose which is an-
other reason for DM-II. Some proteins viz. PTPRN, TGM2, SCARB2, VAPA, CBX3 and SPTBN2
are involved both in the insulin resistance and aberrant glucose metabolism [47]. Further, TAGLN
and VDAC2 are two proteins which are found up-regulated in obesity and as obesity is strongly
associated with DM-II, these proteins stand important for occurrence of the disease. SLC16A1 is
associated with regulation of lipid metabolism and is also a novel protein for diabetes mellitus II [48].
Proteins OTUB1, UCHL1, NQO1 and PSMC5 have significant roles in ubiquitin-proteosome system
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which is regulated in DM-II. Next, expressions of SLC3A2 and IGHA1 are altered which are associ-
ated with excess urination and thereby leading to the disease state as excessive urination is a major
symptom of DM-II. Moreover, VDAC2 and HPRT1 play a major role in house-keeping functions
of the cell by energy regulation. Other proteins C6, C8A, NME3, DDC, FBLN1 and EKB are not
directly related with the onset of the disease and perform house-keeping functions. Elaboration on
above analysis is given in supplementary material. What follows that, out of 34, 28 proteins are
directly responsible for the occurrence of Diabetes mellitus II. The nodes having CC equals to one
common in both the disease and normal have a significant role in the occurrence of the disease.
We further compare these structural properties to various other model networks namely random,
small world network and configuration networks to examine the deviation of the disease and normal
networks from the random controls.
Table 2: The corresponding Erdo˝s-Re´nyi model for all the normal and disease dataset
Network 〈CC〉 Nclus=1 λ0 λ−1
Normal-1 0.005 0 0 0
Normal-2 0.007 0 0 0
Disease-1 0.017 0 0 0
Disease-2 0.027 0 0 0
The parameters show all the results as ensemble average of 10 realizations of Erdo˝s-Re´nyi network
with same N and 〈k〉 as for real networks.
Comparison with various random control networks
Erdo˝s-Re´nyi random model
Erdo˝s-Re´nyi random network is the simplest model proposed about half a century back, to understand
structural properties of real world systems [49]. We generate Erdo˝s-Re´nyi network with the same
number of nodes and average degree as the normal and the disease sub-networks. To create an Erdo˝s-
Re´nyi network, we connect nodes with a fixed probability p, calculated as 〈k〉/N . Since nodes are
connected randomly with the probability p, without any special preference or additional constraints,
this gives rise to the Poisson degree distribution. Properties of Erdo˝s-Re´nyi random networks thus
constructed, are summarized in Table. 2. Owing to the very much nature of construction of the
Erdo˝s-Re´nyi networks, we get very small clustering coefficient (CC ∼ k/N) which further diminishes
the probability of having any node with CC = 1. Additionally, there is no degeneracy found at 0 or
1 eigenvalues.
Small-world network
Since all the disease networks have significantly high value of 〈CC〉 indicating hidden importance of
network interactions contributing to this property, we attempt to model this and investigate using
corresponding small world networks (Table. 3). The small world networks are generated using Watts-
strogatz algorithm [40]. Starting from a regular lattice, connections are rewired with the probability p.
The rewiring probability is chosen in such a manner that it leads to the desired clustering coefficient
matching with the corresponding real networks. It turns out that while for the model network
contribution to the CC comes from almost all the nodes, for the real world networks only 75%−80%
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Table 3: Small world network
Network 〈CC〉 Nclus=1 λ0 λ−1
Normal-1 0.36 0 0 0
Normal-2 0.36 0 0 0
Disease-1 0.32 0 0 0
Disease-2 0.44 0 0 0
Various parameters enlisted for small-world networks corresponding to the normal and disease
sub-networks taking ensemble average of 10 realizations .
nodes contribute to the clustering coefficient of the network and rest of the nodes do not have any
interacting neighbors. i.e. they form star like structure. Additionally, real networks have significant
number of nodes having CC = 1, the property which again is not found in the corresponding model
network. As elaborated in the previous section “preserved structure through clique formation”, the
nodes with CC = 1 have special role in the occurrence of the disease, making the deviation of CC = 1
properties of the nodes from the model networks more crucial.
Table 4: The configuration model for corresponding real world dataset
Network 〈CC〉 Nclus=1 λ0 λ−1
Normal-1 0.023 7 1.5% 0
Normal-2 0.027 4 1.7% 0
Disease-1 0.083 12 4.5% 0
Disease-2 0.123 7 2.1% 0
Ensemble average of 10 realizations for parameters of configuration model corresponding to the
normal and diabetes networks listed for various properties.
Configuration model
Erdo˝s-Re´nyi random and small world networks being the simplest models for capturing various
properties of real systems fail to model one of the very important aspects of many real-world networks.
The degree distribution of Erdo˝s-Re´nyi random networks follow Poisson distribution whereas most
of the real world networks [35], including those investigated here, follow power law behavior. This
power law behavior can be modeled using preferential attachment rule [50], but configuration model
additionally preserves the exact degree sequence of a network [51] and hence we make comparison
with this model which produces an exact random replication of the network considered here. The
configuration model generates a random network with a given degree sequence of an array of size
m = 1
2
∑N
i=1 ki which have random connections among different elements. We generate 10 such
realizations for a given degree sequence.
Properties of the configuration model corresponding to the normal and diabetes sub-networks are
enlisted in Table. 4. The clustering coefficient, inverse participation ratio, of all the configuration
model networks are all same as for the Erdo˝s-Re´nyi random networks as expected from the config-
uration model algorithm, which randomly connects pair of nodes by following only one constraint
that is preservation of the degree of all the nodes. For configuration model, there is an additional
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property which comes out to be different than other model networks that is about degenerate eigen-
values. This occurrence of zero degeneracy is not surprising [52] as power law degree distribution
is known to add into occurrence of high degeneracy at zero [53]. Further, we note that all these
model networks, while acting under one or the other constraint, are basically built up on random
interactions, i.e., the pairs of nodes that should interact are chosen randomly out of many possible
configurations. The feature which real-world systems are supposed to lack and in turn being captured
in various spectral properties. For instance, none of the random controls are able to reproduce high
degeneracy at zero. In addition, there is degeneracy at one as well, which too is not captured by
any of the model networks widely investigated in the network literature reflecting richer interaction
patterns possessed by these real systems. In the next sections, we will delve into understanding the
spectral features of the four sub-networks.
Figure 2: Eigenvector localization for both the normal and disease sub-networks. The
figure shows IPR of both normal (N − 1 and N − 2) and disease (D− 1 and D− 2) network, clearly
reflecting three regions (i) degenerate part in the middle, (ii) a large non-degenerate part which follow
GOE statistics of RMT and (iii)non-degenerate part at both the end and near to the zero eigenvalues
which deviate from RMT.
Localization behavior of spectra
The localization properties of eigenstates have been shown to provide clue to the important nodes
of the network [54]. We calculate the eigenvector localization using IPR (Eq. 3), and based on the
localization behavior, we can divide the individual spectrum into two different components. First
component which follows RMT predictions of Porter-Thomas distribution of GOE statistics [55], and
another one which deviates from this universality and indicates localization (Figure. 2). The very
distinct interpretation of this behavior of universal and non-universal (deviation from universality)
components is that the underlying system has random interactions leading to universal part of the
spectra, as well as non-random, pattern specific interactions contributing to the part of the spectra
deviating from the universality. Further, the average IPR calculated using Eq. 4 for the normal and
disease sub-networks reveal that the sub-networks of normal are less localized than the sub-networks
of disease networks (Table. 1) indicating that the normal sub-networks are more random than the
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disease sub-networks. The fact is that the disease state has less number of connections than that of
the normal one suggests that there are some interactions which are hampered or silenced perhaps
due to mutation leading to the disease state. This interpretation combined with the analysis that
〈IPR〉 of the disease is higher than the normal, indicates that these hampered pathways may be
corresponding to or should be treated as random pathways whose removal result in the diminished
randomness in the disease state. This result can be considered very important as randomness has
already been emphasized as an essential ingredient for the robustness of a system [54] and lack of
sufficient randomness might lead to the disease state.
Table 5: TCNs of Disease-1 sub-network
Ek TCN k CC BC
234 PSMD1, PSMD11, PSMB8 4, 4, 4 1, 1, 1 0, 0, 0
228 PFKP, PFKL, PSMB8, H3.3B 5, 5, 4, 8 0.9, 0.9, 1,
0.75
0, 0, 0,
0.002
229 COL1A2, COL3A1, PSMB8,
H3.F3B
6, 6, 4, 8 0.5, 0.53,
1, 0.75
0.002,
0.002, 0,
0.002
232 PSMB8, PSME1, PSMD11,
H3F3B, H3.3B, PSMD1
4, 4, 4, 8,
8, 4
1, 1, 1,
0.75, 0.75,
1
0, 0, 0,
0.002,
0.002, 0
Top localized eigenvectors (Ek) for the disease D − 1 dataset representing the index of the localized
eigenvector followed by their TCN’s in the next column and network parameters namely degree,
clustering coefficient and betweenness centrality.
Table 6: TCNs of Disease-1 sub-network
Ek TCN k CC BC
281 AVPR2, MT-ND5, MT-ND4 2, 13, 13 1, 0.846,
0.846
0, 0, 0.003
126 MT-ND1, MT-CO3, MT-ND6 12, 1, 12 0.985,
0.985,
0.984
0, 0, 0
141 SEL1L, SELS, C1S, HLA-DQA1 1, 2, 9, 6 0, 0, 0.5,
0.46
0, 0.005,
0.004, 0
261 YWHAE, CALM1, CALM3,
CALM2
1, 6, 5, 5 0, 0.53,
0.80, 0.80
0, 0.009,
0.003,
0.003
Top most localized eigenvectors (Ek) for the disease D − 2 dataset, their top contributing proteins
and network parameters namely degree, clustering coefficient and betweenness centrality.
As discussed, eigenvector localization technique offers the platform to distinguish random and non-
random part of the spectra. The part deviating from RMT can be explored further to get insight
into the important interactions revealed through the top contributing nodes (TCNs). In order to do
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that, we investigate properties of TCNs of both the sub-networks D − 1 and D − 2 as described in
Table. 5 and Table. 6 respectively. There comes out to be 31 TCN’s in the disease sub-networks out of
which 24 are unique. We analyze the structural properties namely, degree, clustering coefficient and
betweenness centrality of these TCN’s in both the sub-networks. The top contributing proteins lie in
the low degree regime demonstrating that they do not take part into many pathways. Additionally,
the betweenness centrality of all the TCNs is nearly zero, indicating a very poor connectivity of these
nodes with the rest of the nodes in their individual sub-network. In coalition, these both rule out a
trivial importance of the nodes in terms of their interactions or connectivity, and hence we shift our
focus to the biological significance of these TCNs and interaction patterns they are forming in the
network.
Functional importance and interaction pattern of top contributing nodes
Figure 3: Interaction patterns of TCNs in disease datasets. Left panel depicts the local
structure of all TCNs in the D− 1 sub-network. Right panel has the interaction pattern of TCNs in
D − 2 sub-network where Diamonds resemble the top contributing nodes and rectangular boxes are
the first interacting partners of these TCN’s.
These TCNs when looked for their functional properties are found to be significantly important
in DM-II. Among all the TCNs, SEL1L, SELS, PFKL and PFKP are associated with the glucose
stimulated insulin secretion. In disease state SEL1L and SELS proteins are found to be under-
expressed [56] whereas PFKL and PFKP over-express [57]. In addition to the above proteins, C1S,
YWHAE, CALM1, CALM2, CALM3 and MT-CO3 are responsible for obesity in turn regulating
levels of insulin leading to insulin resistance in the body and thus contributing to the occurrence
the disease [58–60]. The proteins PSMD1, PSMD11, PSME1 and PSMB8 form a complex in the
proteosome accounting for ATP dependent protein degradation and in disease state are found to
be down regulated or absent which is directly related to obesity and DM-II [61, 62]. Further, MT-
ND5, MT-ND4, MT-ND1 and MT-ND6 collectively are the components in mitochondria involved in
insulin signaling and resistance as well as alteration in the cell leading to DM-II [63]. Additionally,
increased levels of AVPR2 leads to glucose induced water loss in the body, hence leading to the disease
state [64]. Protein HLA-DQA1 plays a central role in immune system and over expression of this
protein increases the susceptibility to DM-II [65]. Furthermore, there are some TCNs localized but
are not directly involved with DM-II namely COL1A, COL3A1, H3.3B and H3F3B. These proteins
are found to play an important role in complications related to heart, lung and kidneys in turn
leading to the symptoms of DM-II like regulated levels of glucose absorption in blood and urinary
complications [66, 67]. A detailed functional information of all these proteins are discussed in the
supplementary material.
Next, we analyze the structural patterns of the TCNs in both the disease sub-networks. D−1 sub-
network reveals the formation of cliques of order three for all the top contributing nodes (Figure. 3).
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This depicts that they are all involved in the same kind of pathways which is confirmed by studying
the functional properties of these proteins briefly discussed above in this section. Further, the TCNs
of D − 2 sub-network too comprise of complete subgraphs (Figure. 3). The functional properties
discussed above demonstrates that these TCNs form complexes as they perform same kind of functions
e.g. proteosome complex (PSMD1, PSMD11, PSME1 and PSMB8), mitochondrial components (MT-
NDs), collagen family (COL3A1 and COL1A) and histone complexes (H3.3B and H3F3B), details of
which are explained in supplementary material. Thus, the interaction patterns of both the networks
of disease dataset reveal that there are nodes pertaining to clique formations which indicate a robust
and stable system as discussed in the section on “preserved structure through cliques”.
Figure 4: Interaction patterns of disease TCNs in normal datasets. The local structural
patterns for the disease TCNs in the normal network. The left and right panels represent N − 1 and
N −2 sub-networks respectively resembling Diamonds as the top contributing nodes and rectangular
boxes as the first interacting partners of TCN’s. The same TCNs in normal sub-networks possess
more interactions than the disease sub-networks.
Thereafter, we compare the interaction patterns of TCNs in the disease state with their interaction
patterns in the normal. Out of 24 TCNs in disease state, 10 are also found in the normal dataset.
The interaction pattern of the disease TCNs in normal sub-networks possess clique like structures.
The TCNs in normal dataset have comparatively high degree than in the disease state indicating
more interactions. This may be due to silencing of various pathways (e.g. insulin signaling, glucose
metabolism etc) from normal to the disease state as discussed earlier. The structural patterns
indicate that even after less interactions in the disease state, the cliques of order three are not
destroyed reflecting that the minimum criteria of maintaining the functionality of the networks are
preserved. This may be due to addition of new proteins in the diseased state or interactions among
themselves. In addition, the interacting patterns of these TCNs illustrate the phenomena of gene
duplication i.e. a pair of node having exactly same interacting partners [68]. Here, out of the
10 TCNs common in both the states, two pairs of nodes namely C1S-CALM2 and PSME1-PFKP
in the normal dataset possess the phenomena of gene duplication which is lost in the disease state
(Figure. 4). Gene duplication has structural and functional significance as fluctuations or destruction
in the interactions can either cause imbalance of genetic material or lead to the generation of new gene
products resulting in diseases [69]. In TCNs, the proteins possessing gene duplication behavior affects
the major pathways namely insulin resistance and pathways promoting obesity in turn resulting
in DM-II. Thus, proteins revealed through the localization properties of spectra have interaction
patterns which may be important as targeting sites for drug development of DM-II.
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Conclusions
We analyze the pancreatic cells for the normal and disease states to get a deep overview of DM-
II under the combined framework of network theory and random matrix theory. The structural
properties namely average degree, diameter, clustering coefficient and degree distribution of both
the networks follow almost similar predictions as for the other biological networks [42]. The average
degree of all the normal and disease sub-networks is nearly same indicating that the disease state has
some altered interactions and some new connections. The diameter of disease sub-networks is less
than the normal which indicates that a reaction may get completed in few steps in turn increasing the
rate of reaction and faster communication in processing a biological function. The degree distribution
of all the normal and the disease sub-networks follow the power law behavior, the property which is
known to make a system robust [42]. Interestingly, despite so many alterations in the interactions,
disease networks still exhibit this property possessed by the normal networks indicating robustness
and complex nature of interactions in the disease state. This could be one of the possible reasons of
failure or poor response of drugs for DM-II [70].
The interesting observation comes out from the nodes having CC equal to one indicating existence
of clique structure in the network and since cliques are considered as preserved structures during the
evolution making the system more robust and stable, we investigate biological functions of these
nodes. It turns out that the nodes having CC equals to one play an important role in the occurrence
of the disease. They are involved in important pathways like insulin resistance, glucose metabolism
and obesity which are directly related to type II diabetes.
Further, we compare properties of normal and disease sub-networks with those of various model
networks to get a deeper understanding of various characteristic properties of networks under con-
sideration. While corresponding model networks capture one or many structural properties of real
world networks, the high degeneracy of eigenvalues found for the real networks are not observed for
any of the model networks. Since, model networks are built using some algorithm, which connects
pair of nodes using some probability distribution, deviation of this property of real world networks
from that of model networks reflect that there are non-random interactions in the real world system
which in turn leads to the formation of patterns, hence affecting the spectra of the network, leading
to specific deviation of its properties from the corresponding random controls.
Furthermore, the spectral analysis of both the networks, by calculating the localization properties
of eigenvector through IPR, reveals that the the disease sub-networks are less random than the normal
one. Randomness in network connections or interactions has already been emphasized for the proper
functioning of various complex systems [71–75]. The revelation that the disease network is less random
than the normal one, detected through the RMT techniques, is an important step to complex systems
research at the fundamental level. It indicates that sufficient randomness is an essential ingredient
for proper functioning of the system leading to a normal state, lack of which causes the disease. The
TCNs of the most localized eigenvectors lie in the low degree regime and have almost zero betweenness
centrality, exhibiting no trivial structural importance. But they form important structural patterns
as out of 24 TCNs, 21 have been found to form cliques with other proteins. Since, clique structures
have been emphasized to be important for robustness of the underlying system [44], the proteins
forming cliques here indicate that as random perturbations in the network leaves the system stable.
This may also lead to ineffective drugs and treatments to the patients as also predicted from the
power law behavior discussed earlier in this section. The functional examination of these TCNs
demonstrates that out of 24, 20 proteins have biological significance in the occurrence of the disease
by involving in crucial pathways related to DM-II such as insulin signaling and resistance. These
structural and functional implications reflect that the localization property reveals important nodes
of the network.
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We investigate interactions of TCN in normal dataset as well. It is found that 10 TCNs from
the disease dataset are common in the normal dataset. The connections among common TCNs form
the same conserved structure i.e. clique. In addition, there are two pairs of TCNs in the normal
dataset which follow the phenomena of gene duplication which is lost in the disease network. It
is already known that the alterations or destructions in the interactions having gene duplication
leads to disease state [69]. On one hand, the revelation that the number of interactions of TCNs
in normal dataset is more than that those observed in the disease indicates silencing of pathways
in the disease state. On the other hand, comparison of structural patterns of TCNs in the normal
and disease states reveals that even after removal of various connections probing to gene duplication
either by forming new connections with new proteins or within themselves in the disease condition,
the underlying system subsists. Thus, these patterns may play an important role in depicting novel
drug targets taking them as site of action. It would be noteworthy to mention here that though the
disease-implicating proteins revealed through our analysis belong to certain parts of the interaction
network, they are detected through spectral analysis of the whole matrix and takes into account all
interactions providing a holistic approach.
To conclude, we provide a platform to detect important proteins revealed through structural
patterns in DM-II using network approach and random matrix theory. The analysis suggests that
instead of targeting individual proteins, a group of proteins forming particular interaction patterns
should be taken into consideration for drug development. This approach, though based on sophisti-
cated mathematical techniques, is time-efficient and cost-effective and paves a way to look into the
diseases from a different perspective by taking the whole system into consideration. For the first
time RMT is applied to analyze the DM-II and our work demonstrates that it can be modeled using
appropriate ensemble of RMT. Being the first step, the approach holds the potential to provide a
new dimension to disease research. RMT is a very well developed branch of physics and continues to
witness emerging techniques and concepts [76, 77]. Appreciating the applicability of this technique
in uncovering crucial information about DM-II, other well developed tools of RMT can be used to
gain more insight into the complexity of DM-II and decipher important entities and their structural
patterns significant in other diseases. Moreover, our work on one hand presents a new tool to identify
proteins responsible for occurrence of the disease and predicts interaction patterns for drug targets,
while on the other hand provides insight into complexity of the disease at the rudimentary level.
The analysis exemplifying the structural and functional significance of these proteins indicates that
rather than individual units, the whole interaction pattern can be treated as a target for drug devel-
opment providing a new direction to treatment of the disease. This approach can also be extended
in composition of novel drugs, conceptualization of single drug therapy for multiple diseases [78, 79]
and devising personalized therapy [80] being especially beneficial for low-income countries.
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Supporting Information Legends
Supporting information file for the article “Interaction patterns in diabetes mellitus II
network: An RMT relation”
Figure S1. Degree-CC Correlation. The degree-CC correlation for the normal (N-1 and N-2)
and disease (D-1 and D-2) networks showing negetive correlation and following power law.
Figure S2. Nodes having CC-1. Degree distribution for the normal (N-1 and N-2) and disease
(D-1 and D-2) datasets for nodes having CC=1.
Table S1. Biological functions. Functional description of proteins having CC=1.
The supplementary file also accompanies functional properties of other common proteins having
CC=1, the top degree node in disease and normal state followed by top contributing nodes of
disease networks achieved through the localization properties in detail.
19
Supporting Information
Relation between diabetes mellitus type II and obesity
Obesity and T2d have a complex but direct relationsheep. Obesity stands out as a primary risk factor
for T2D. According to its participation in T2D it can be assumed as a precursor for it, followed by
insuline leading T2D [1–3].
Degree clustering correlation
Furthermore, the degree and CC of all the sub-networks of the normal as well as disease are negatively
correlated (Figure.1) as found for other biological systems. [4]. he degree and CC of the normal and
the disease networks are negatively correlated (Figure.1), as found in the case of other biological
systems. This negative correlation indicates that the low degree nodes tend to form modules which
are connected through the high degree nodes for proper functioning of a system [5].
Degree distribution of nodes having CC=1
Out of 72 proteins, the least degree a protein can have is two as all these proteins have CC = 1
indicating that they are part of atleast a lowest order clique of size three. There are 42 proteins have
degree two. What follows that the lower degree proteins lying towards periphery should correspond to
end product. Since all these nodes having CC = 1 have zero to close to zero betweenness centrality
confirm that this indeed is the case of the these nodes and suggest that they are not involved in
many pathways. Although there are many proteins which correspond to end products lying on the
periphery of the network having degree one (Fig. 2), we concentrate here on those proteins which in
addition to have less degree has property of having CC = 1.
Functional properties of common proteins having CC=1
CTNNB1(Catenin(cadherin-associated protein), beta 1, 88kDa)- It is a part of WNT sig-
naling pathway which plays important role in several processes like adipogenesis, fat production,
strong activator of mitochondrial biogenesis, also leads to increased production of reactive oxygen
species(ROS). This ROS-induced damage is significant because it can cause the development of acute
hepatic insulin resistance, or injury induced insulin resistance. In diseased cells single nucleotide
polymorphisms in -cat/TCF lowers -catenin levels which leads to the alteration or mutation of WNT
signaling pathway make cells more susceptible to the development of T2D [6–11].
Summary- This protein is involved in WNT signaling pathway, which has important role in
increased production of reactive oxygen species(ROS) which leads to insulin resistance (main cause
of T2D).
TGM2(Transglutaminase 2)- It is a multi-functional enzyme which catalyzes transamidation
reactions or acts as a G-protein(guanosine nucleotide-binding protein) in intracellular signaling in
normal cells. In disease cells lacking TGM2 makes them glucose intolerant and show impairment of
insulin secretion, suggesting an important physiological role for TG2 in the pancreatic cell [12].
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and disease (D-1 and D-2) networks showing negetive correlation and following power law.
Summary- This acts as a G-protein in intracellular signaling in normal cells. Mutation in this
leads to abnormal insulin secretion and glucose intolerance.
SCARB2(Scavenger Receptor Class B, Member 2/ Lysosome membrane protein 2)- It is
a class B scavenger receptor normally functions as membrane protein whose expression is prevalent
in vascular lesions. Raised levels of glucose, insulin resistance, low HDL cholesterol, increased levels
of free fatty acid (FFA) all result in increased expression of CD36, thereby contributing to T2D.
Adipocytokines such as tumor necrosis factor-alpha (TNF-), C-reactive protein (CRP), adiponectin,
leptin, resistin along with peroxisome proliferator activated receptor- (PPAR-) are important me-
diators in glucose homeostasis in association with CD36 and can be used as markers for T2D and
atherosclerosis. Several of these gene variants have shown association with lipid metabolism, T2DM
and related complications [13].
Summary- It is a class B scavenger receptor, its increased expression leads to Raised levels of
glucose, low HDL cholesterol, increased levels of free fatty acid (FFA), and insulin resistance.
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TAGLN(Transgelin) Expression level of this protein is up-regulated during obesity and leading
T2D. A functional role of this protein is unclear. Two transcript variants encoding the same protein
have been found for this gene [14, 15].
Summary- Expression level of this protein is up-regulated during obesity and leading T2D.
SPTBN2(Spectrin, Beta, Non-Erythrocytic 2 )- It is a component of Cell membrane-cytoskeleton
and is composed of two alpha and two beta spectrin subunits. Also regulates the glutamate signaling
pathway and insulin signaling. In diseased cells due to increased protein glycosylation it is responsible
for membrane abnormalities and develop insulin resistance causing T2D [16, 17].
Summary- This protein regulates the glutamate signaling pathway and insulin signaling. In
diseased cells due to increased protein glycosylation it is responsible for membrane abnormalities and
development of insulin resistance causing T2D.
VAPA(Vesicle-associated membrane protein-associated protein A)- It is present in the
plasma membrane and intracellular vesicles. It is associated with the cytoskeleton, vesicle trafficking,
membrane fusion, protein complex assembly and cell motility, and also acts as receptor in Calcium
signaling toolkit in normal cells. In diseased cells its expression got decreased with -1.35 folds which
directly affects cell adhesion and vascular complications in T2D. any alteration in Ca2+ signaling
adversely effects on cell survival and insulin secretion leading T2D [18, 19].
Summary- This protein playes important role in insulin secretion as receptor in Calcium signal-
ing toolkit, and alteration in expression affects insulin secretion.
PTPRN(Receptor-type tyrosine-protein phosphatase-like N)- It is involved in Ca2+ -regulated
pathway as receptor in INS-1 cells which relates with glucose-induced exocytosis of insulin secretory
granule (ISGs) in their biogenesis. Also regulate glucose stimulated -cell proliferation. Destruc-
tion and dysfunction of the insulin-producing beta cells in the pancreas directly leads to T2D. And
Deletion of PTPRN resulted in mild glucose intolerance and decreased glucose-responsive insulin
secretion [20–24].
Summary- In ca2+ regulated pathway and glucose stimuilated B-cell proliferation, dysfunction-
ing or deletion makes cells glucose intolerance and decreased glucose-responsive insulin secretion and
leads to T2D.
PYCR1(Pyrroline-5-Carboxylate Reductase 1)- It catalyzes the NAD(P)H-dependent conver-
sion of pyrroline-5-carboxylate to proline in normal cells. its upregulation in high glucose conditions
leads to the development of various diabetic complications including cardiovascular diseases, dibetic
nephropathy, and retinopathy through upregulating cytokines such as TNF-a, IL-1B, IL-6, and MCP-
1 in monocytes, by the IFN-a pathway which leads to T2D [25–35].
Summary- This protein catalyzes conversation of proline in normal cells, and upregulation in
diseased cells leads to alteration of IFN-a pathway and ultimately to T2D.
OTUB1(Ubiquitin thioesterase OTUB1/otubain-1)- It interacts with another protien ubiq-
uitin protease and an E3 ubiquitin ligase that inhibits cytokine gene transcription in the immune
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system. It participates in specific Ubiquitin- Proteasome pathway /complex, which has a major role
in targeting cellular proteins for ATP dependent degradation by the 26S. Any alteration or change
in this pathway makes cell more susceptible to T2D [36–38].
Summary- This protein interacts with ubiquitin protease and thus participate in Ubiquitin- Pro-
teasome pathway, which playes major role in targeting cellular proteins for ATP dependent degrada-
tion by the 26S makes cell more susceptible to T2D.
SLC3A2(4F2 cell-surface antigen heavy chain)- In normal cells mainly functions for renal
handling of citrat, oxidative metabolism, codes for 4F2 heavy chain (activator of dibasic and neu-
tral amino acid transporters) and also involved in the transport of the bulky branched-chain amino
acids which are very important in regulation of blood pressure and urine excretion and water re-
absorption. 4F2hc can interact with GLUT1; such interaction promotes the stabilization of GLUT1
and contribute to the regulation of glucose metabolism. In diseased cells its expression gets upregu-
lated and responsible for excessive urine excretion and alteration in SKG1 signaling pathway leading
T2D [39–46].
Summary- This protein mainly functions for renal handling, its increased expression leads to
excessive urine excretion.
VDAC2(Voltage-dependent anion-selective channel protein 2 )- It is a Part of voltage depen-
dent anion channel (VDAC) which playes important role in cellular energy regulation, mitochondrial
cell apoptpsis in normal cells. And due to its functional importance it is directly associated with
T2D and helps us in understanding of pathological conditions such as obesity and T2D [47–51].
Summary- This protein is a part of voltage dependent anion channel (VDAC) which playes major
role in cellular energy regulation, mitochondrial cell apoptpsis, and any alteration in functioning if
this channel leads to obesity and T2D.
UCHL1(Ubiquitin Carboxyl-Terminal Esterase L1 (Ubiquitin Thiolesterase))- It is a thiol
protease that hydrolyzes a peptide bond at the C-terminal glycine of ubiquitin, specifically expressed
in the neurons and in cells of the diffuse neuroendocrine system in normal cells. It is an important
component of the ubiquitin-proteasome system. It increases the available pool of ubiquitin to be
tagged onto proteins destined to be degraded by the proteasome. In diseased cells Loss of Uchl1
increases the susceptibility of pancreatic beta-cells to programmed cell death, indicating that this
protein plays a protective role in neuroendocrine cells and illustrating a link between T2D and
neurodegenerative diseases. This gene is specifically expressed in the neurons and in cells of the
diffuse neuroendocrine system. Mutation in this gene leads to T2D [52–54].
Summary- This protein is a Component of the ubiquitin-proteasome system, In diseased cells it
increases the susceptibility of pancreatic beta-cells to programmed cell death, mutations in this gene
leads to T2D.
HPRT1 ( hypoxanthine phosphoribosyltransferase 1)- Nucleotide salvage enzymes adeny-
losuccinate synthetase and adenylosuccinate lyase were elevated above normal in the diabetic heart,
whereas hypoxanthine-guanine phosphoribosyl transferase was not altered [55].
Summary- Housekeeping function.
NME3 (nucleoside diphosphate kinase 3)- Major role in the synthesis of nucleoside triphos-
phates other than ATP. The ATP gamma phosphate is transferred to the NDP beta phosphate via
a ping-pong mechanism, using a phosphorylated active-site intermediate. Probably has a role in
normal hematopoiesis by inhibition of granulocyte differentiation and induction of apoptosisn [56].
Summary- It is not directly involved in diabetes mellitus II.
CbX3 (carbenoxolone 3) - It is shown to improve insulin sensitivity when dosed to healthy
human. When it is dosed to lean type 2 diabeteic patient, improved insulin sensitivity, reduced
glucose production and glycogenolysis were reported [57].
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Protein Function
ADAMTS9 pancreatic beta cell dysfunction and decrease in insulin
sensitivity.
NR2C2 down-regulation leading to hypoglycaemia which is di-
rectly related to TYD
C6 gluconeogenesisleads to deficiency in insulin sensitivity
G5A involved in glycolysis pathway useful for glucose produc-
tion
IGHA1 immunoglobulin related to the functioning of pancreatic
cells
C8A gluconeogenis and in disease state leads to decrease in-
sulin sensitivity
PIK3C2A present in mitochondria and leads helps in energy trans-
fer
AGER involved in glycolytic pathway and in disease state it is
down-regulated which leads to less insulin uptake in the
body
NQO1 is downregulated in obesity and as obesity is directly
related to TYD it is directly involved.
FBLN1 It is a marker for arterial extracellular matrix alterations
in type 2 diabetes
CACNA1D is downregulated in the disease state which is associated
with calcium transport in the cell.
EKB is a drug molecule associated with the growth factors of
a cell and are associated with various cancers
SLC16A1 alters lipid metabolism, most notably causing an in-
crease in intracellular triacylglycerol levels. It has been
targeted as a novel candidate protein for type 2 diabetes
with a possible role in triacylglycerol metabolism.
CD59 CD59 impairs complement regulation on erythrocytes
leading to poor glycaemic control in diseased sate.
SI Table 1: Biological functions. Functional description of proteins having CC=1.
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Summary- Involvement in insulin sensitivity, reduced glucose production and glycogenolysis.
Ddc (dopa decarboxylase)-It does not have a direct role in occuring DM-II. It is found to Catalyze
the decarboxylation of L-3,4-dihydroxyphenylalanine (DOPA) to dopamine, L-5-hydroxytryptophan
to serotonin and L-tryptophan to tryptamine [58].
Summary-It is not directly involved.
SERPINA3(Alpha 1-antichymotrypsin)- In normal cells Alpha 1-antichymotrypsin inhibits the
activity of enzymes as proteases, cathepsin G that is found in neutrophils, and chymases. Also serum
SERPINA3 levels were higher in T2D which leads to increase in permeability of retinal microvascular
endothelial cells, which are involved in the pathogenesis of T2D and/or diabetic retinopathy. Also
associated with acute renal allograft rejection [59–62].
Summary- This inhibits the activity of enzyme like proteases in neutrophils, and upregulation
of its expression level leads to increase in permeability of retinal microvascular leading T2D. And it
is also associated with acute renal allograft rejection.
PSMC5(Proteasome (Prosome, Macropain) 26S Subunit, ATPase, 5)- In normal cells it
is part of Ubiquitin- Proteasome complex which has a major role in targeting cellular proteins for
ATP dependent degradation by the 26S. In diseased cells functioning of this complex is either less or
absent in which primly leads to T2D [37, 38, 63].
Summary- This protein playes a major role in Ubiquitin- Proteasome complex which is involved
in targeting cellular proteins for ATP dependent degradation by the 26S, downregulation of its
expression leads to T2D.
ANPEP (alanine aminopeptidase):- In normal cells it is involved in the metabolism of regulatory
peptides in renal tubular epithelial cells, and in diabetes is assumed as a primary biomarker due to its
increased presence in urine due to Renal tubular dysfunction which leads to T2D or vice versa [64].
Summary- This protein acts as a biomarker due to increased concentration in urine due to
renal/kidney dysfunction leading T2D.
PDE3B(Phosphodiesterase 3)- In normal cells it works in insulin secretion, insulin signaling
pathway and fat metabolism. In diseased cells reduced expression of PDE3B in adipose tissue acts
as primary event in the development of insulin resistance [65].
Summary- This protein playes important role in insulin resistance and insulin signaling pathway,
reduced expression leads to T2D.
Functional properties of proteins denoted as top degree node
in disease
UBB(Ubiquitin B)- It is our 1st top degree node in disease cell line D1 which scored degree of 112
among high degree nodes and bears 444 as its node index. This protein is one of the most conserved
proteins known. In normal cell line it scores a degree 40 and bears 1458 as its index no. In normal
cells it is part of Ubiquitin- Proteasome complex which has a major role in targeting cellular proteins
for ATP dependent degradation by the 26S. In diseased cells functioning of this complex is either
less or absent in which directly leads to T2D [37, 38].
INS (Insulin)-It is our 1st top degree node in disease cell line D2 which scored degree of 148 among
high degree nodes and bears 60 as its node index. In normal cells it scores a degree 118 and bears
111 as its index no and also bears a position of 1st top degree node in normal cell line N3. In normal
cells Insulin functions in the normalization of the elevated blood glucose level. But in T2D cells are
resistant of insulin and production of insulin gets decreased which directly leads to T2D [66].
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Functional properties of proteins denoted as top degree node
in normal
UBC(Ubiquitin C)- It is our 1st top degree node in normal cell line N1 which scored degree of 182
among high degree nodes and bears 1459 as its node index. This protein is one of the most conserved
proteins known. In disease cell line it is absent. In normal cells it is a part of Ubiquitin- Proteasome
complex which has a major role in targeting cellular proteins for ATP dependent degradation by the
26S. In diseased cells functioning of this complex is either less or absent in which primly leads to
T2D [37, 38].
ALB(Albumin)- It is our 2nd node in normal cell line N1 which scored degree of 148 among high
degree nodes and bears 414 as its node index. In disease cell lines it has 146 and 79 degree in D1
and D2 respectively. It is as globular, negatively charged, water-soluble protein that is synthesized in
the liver. In normal cells functions include maintaining osmotic pressure and transporting a variety
of circulating molecules. In diabetes it functions for the same but its production level get slightly
elevated in T2D [67–69].
CD4(cluster of differentiation 4)- It is our 3rd node in normal cell line N1 which scored degree
of 121 among high degree nodes and bears 1883 as its node index. In disease cell line it is less
functional or absent. In normal cells it functions as a co-receptor that assists the T cell receptor
(TCR) in communicating with an antigen-presenting cell. CD4 also interacts directly with MHC
class II molecules on the surface of the antigen-presenting cell using its extracellular domain [70].
AKT1(alpha serine/threonine-protein kinas)- It is our 4th node in normal cell line N1 which
scored degree of 108 among high degree nodes and bears 1440 as its node index. In disease cell line it
has 309 as its index no. This protein is named as RAC-alpha serine/threonine-protein kinase a sub
unit of serine/threonine kinase AKT that plays a key in regulating cell survival, insulin signaling in
normal cells. But alteration in its activation pathway directly leads to insulin resistance and leads
to T2D [71–73].
UBA52(Ubiquitin A-52 Residue Ribosomal Protein Fusion Product 1)- It is our 1st top
degree node in Normal cell line N2 which scored degree of 106 among high degree nodes and bears
604 as its node index. This protein is one of the most conserved proteins known. In disease cell line
it scores a degree 86 and bears 282 as its index no. In normal cells it is part of Ubiquitin- Proteasome
complex which has a major role in targeting cellular proteins for ATP dependent degradation by
the 26S. In diseased cells functioning of this complex is either less or absent in which primly leads
to T2D. Sometimes Selective expression of UbA52 in the renal tubules suggests that the ubiquitin-
proteasome proteolytic system is indeed operative in this compartment of the kidney and might play
an important role in diabetic nephropathy. Its release in urine can potentially work as a diagnostic
marker [37, 38, 74, 75].
TP53 or P53(Tumor protein p53)- It is our 2nd node in normal cell line N2 which scored degree
of 105 among high degree nodes and bears 710 as its node index. In disease cell line it is absent. In
normal cell it encodes the tumor suppressor protein p53, which is known to be involved in cell-cycle
control, apoptosis and maintenance of genetic stability, thereby protecting the organism from cellular
damage. P53 is expressed in all tissues, but at very low levels under normal conditions [76, 77].
IL6(Interleukin-6)- It is our 2nd and last top degree node in Normal cell line N3 which scored
degree of 111 among high degree nodes and bears 528 as its node index. In disease cell line it scores a
degree 2 and bears 276 as its index no. In normal cells it acts as a cytokine and not only involved in
inflammation and infection responses but also in the regulation of metabolic, regenerative, signaling,
and neural processes. Specific co-relation between T2D and IL-6 is not specified but increased serum
levels of interleukin 6 (IL-6) are associated with increased risk of T2D and insulin resistance [78–81].
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Functional properties of disease proteins denoted as top con-
tributing node (D1)
PFKL and PFKP(Phosphofructokinase, Liver and platelet)- In normal cells these are sub-
units of enzyme called PFK which has key activity in glycolytic pathway and insulin secretion. PFKL
and PFKP are isoforms designated as M, P and L for muscle-, platelet-, and liver-type isoforms, re-
spectively. Over expression of PFKL and increased activity of PFK is associated with altered insulin
secretion and increased glycolysis rate [82–85].
Summary- These protein participates in glycolytic pathway and insulin secretion, Their Over
expression of leads to alteration in insulin secretion and glycolysis rate.
COL1A2 and COL3A1(Collagen alpha-2(I) chain and Collagen alpha-1(III) chain)- In
normal cells encodes one of the chains for type I collagen, the fibrillar collagen found in most con-
nective tissues, But in diseased cells due to decreased expressions leads to several heart and lungs
related complications [86, 87].
Summary- These proteins encodes chains for type I collagen in normal cells, But decreased
expression levels leads to several heart and lungs related complications.
H3.3B AND H3F3B(Histone H3) - In normal cells functions in transcription regulation, DNA
repair, DNA replication and chromosomal stability. In diseased cells due to some modifications and
alteder expression levels leads to several heart and renal complications [88].
Summary- These proteins participates in transcription regulation, DNA repair, DNA replication
and chromosomal stability. Altered expression levels leads to several heart and renal complications.
PSMD1, PSMD11, PSME1, PSMB8(26S proteasome non-ATPase regulatory subunit
1, 26S proteasome non-ATPase regulatory subunit 11, Proteasome activator complex
subunit 1, Proteasome subunit beta type-8)- These all proteins are subunits of proteasome
complex which participates in ubiquitin-proteasome pathway, which works in targeting cellular pro-
teins for ATP dependent protein degradation by 26s. In diseased cells functioning of this complex is
either less or absent which leads to obesity and T2D [2, 3, 37, 63, 89].
Summary- These proteins are involved in targeting cellular proteins for ATP dependent protein
degradation by 26s. But less or absent expression levels leads to obesity and then T2D.
Functional properties of disease proteins denoted as top con-
tributing node (D2)
AVPR2(Arginine vasopressin2)- It is a subunit of Arginine vasopressin (AVP) complex or anti-
diuretic hormone, it act as receptor v2 which is responsible for stimulating water retention. Increased
expression levels leads to cardio vascular complications, mortality and also limits glucose-induced
water loss in T2D [90–92].
Summary- This protein act as receptor v2, which is responsible for stimulating water retention.
Increased expression levels leads to cardio vascular complications, mortality and also limits glucose-
induced water loss in T2D.
MT-ND5, MT-ND4, MT-ND1, MT-ND6- These are subunits of respiratory complex 1 (NADH:
ubiquinone oxidoreductase) encoded by mitochondria. They participates in oxidative phosphoryla-
tion, ion exchange, cell signaling, insulin signaling and insulin resistance. Any alteration in mito-
chondrial genome leads to T2D [93–99].
Summary- These proteins are involved in insulin signaling and insulin resistance. Alteration in
any of these proteins genome leads to T2D.
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MT-CO3(Mitochondrially Encoded Cytochrome C Oxidase III)- This protein functions
as an enzyme complex which playes vital roles in body weight regulation, in diseased cells due
to decreased expression levels leads to mitochondrial dysfunction, obesity, insulin resistance, and
T2D [100–104].
Summary- This protein functions as an enzyme complex which playes vital roles in body weight
regulation, in diseased cells due to decreased expression levels leads to mitochondrial dysfunction,
obesity, insulin resistance, and T2D.
SEL1L(Suppressor Of Lin-12-Like) and SELS/VIMP (Selenoprotein S/VCP-Interacting
Membrane Protein)- They are ER(endoplasmic reticulum) membrane protein, which functions
for retrotranslocation of misfolded proteins from the endoplasmic reticulum in normal cells, but in
diseased cells a deficiency of SEL1L and SELS causes systemic ER stress leading retarded glucose-
stimulated insulin secretion leading T2D [105, 106].
Summary- These proteins functions in retrotranslocation of misfolded proteins, Their deficiency
leads systemic ER stress leading retarded glucose-stimulated insulin secretion leading T2D.
CALM1, CALM2, CALM3(Calmodulin 1,2,3)- These are members of the EF-hand calcium-
binding protein family (calmodulin) which plays vital role in Calcium/Calmodulin-Dependent Protein
Kinase II pathway responsible in insulin signaling. Their decreased expression levels leads to insulin
resistance and obesity causing T2D [107].
Summary- These proteins functions in Calcium/Calmodulin-Dependent Protein Kinase II path-
way. Their decreased expression levels leads to insulin resistance and obesity causing T2D.
HLA-DQA1(Major Histocompatibility Complex, Class II, DQ Alpha 1)- It plays a cen-
tral role in the immune system by presenting peptides derived from extracellular proteins. Class II
molecules are expressed in antigen-presenting cells (APC: B lymphocytes, dendritic cells, macrophages).
In diseased cells its increased expressions subsequently increases susceptibility for T2D [108, 109].
Summary- This protein plays important role in immune system, and in diseased cells its increased
expressions subsequently increases susceptibility for T2D.
C1S(Complement Component 1, S Subcomponent)- It is a serine protease that combines with
C1q and C1r to form C1. It plays an important role in the initiation of inflammatory process, in
diseased cells Upregulation of C1s expression in adipose cells leads obesity and insulin resistant in
T2D [110].
Summary- This protein is responsible for initiation of inflammatory process, upregulation in its
expression leads to obesity and insulin resistant.
YWHAE(tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein,
epsilon)- In normal cells it functions in signal transduction by binding to phosphoserine-containing
proteins in insulin signaling and sensitivity, alteration in its expression levels leads to obesity and
T2D [111].
Summary- This protein functions in signal transduction and alteration in expression levels causes
defect in insulin secretion and sensitivity and obesity.
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